Background: Recent findings demonstrated that, in mammalian cells, telomere DNA (Tel) is transcribed into telomeric repeat-containing RNA (TERRA), which is involved in fundamental biological processes, thus representing a promising anticancer target. For this reason, the discovery of dual (as well as selective) Tel/TERRA G-quadruplex (G4) binders could represent an innovative strategy to enhance telomerase inhibition.
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INTRODUCTION
Beyond the canonical double helix [1] , both DNA and RNA nucleic acids can also adopt noncanonical higher-order structures called G-quadruplexes (G4s). G4s are formed in single-stranded guanine-rich (G-rich) sequences. In these G-rich sequences, four guanines can self-associate into a square-planar platform, called G-quartet, where each guanine is linked through Hoogsteen-type hydrogen bond network and the oxygen O6 atoms are arranged to coordinate metal cations. Gquartets can π-stack upon each other forming four-stranded helical structure known as G4s [2] . In these last years, several studies reported that both DNA and RNA G4s are associated with many important biological processes [3, 4] . Specifically, DNA G4s have been shown to form into biologically significant regions of the genome, such as human telomeres (composed of TTAGGG repeats) [5] , oncogene promoter regions [6] , immunoglobulin switch regions [7] and ribosomal DNA [8] . By contrast, RNA sequences forming G4s motifs have been retrieved from the human transcriptome, particularly at the 5' untranslated regions (UTRs) of mRNAs, which have been shown to be involved in the post-transcriptional regulation of gene expression [9] . In addition to the 5'-UTRs regions, a recent study has shown that also mammalian telomeres can be transcribed into telomeric repeat-containing RNA (referred to as TERRA) containing UUAGGG repeats forming G4s conformations of heterogeneous length [10] . The direct evidence of the presence of the parallel-stranded TERRA RNA G4s in living cells has been also demonstrated by using a lightswitching pyrene probe by Xu and co-workers [11] . Such an evidence provided a useful information to deeper understand the structure and the biological function of TERRA RNA G4. In fact, it has been hypothesized that the presence of TERRA at the chromosome ends may represent a new level of regulation and protection of telomere, suggesting a possible association between TERRA RNA and telomere DNA (Tel), with a possible clinical relevance in the treatment of cancer. All such findings can trace the route for a new anticancer strategy based on ligands that selectively (or not)
bind to the RNA G4s. The availability of telomeric RNA G4 experimental structures (NMR and XRay) and a deep understanding of their topologies are crucial to design RNA G4s selective ligands.
In fact, a little structural diversity has been found, in telomeric RNA G4 with respect to its DNA G4 counterpart. CD, NMR, and X-ray crystallography have shown that G-rich telomeric RNA sequences form bimolecular parallel G4s (TERRA 2 ) both under Na + and K + conditions [12] [13] [14] .
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ACCEPTED MANUSCRIPT 4 selectivity of a naphthalene diimide ligand -bearing hydroxyl groups (compound c in Fig. 1 ) in binding bimolecular RNA G4s with respect to , which, in turn, has higher affinity for Tel DNA G4. Such an observation could be due to the presence of the 2'-OH groups in the ribose sugar at the apices of the RNA G4, which may constrict the space available to the ligand side-chains to interact with the loops by reducing the depth and the width of the UUA loops [16] . Therefore, the presence of multiple hydrogen bonds involving the O2′ hydroxyl groups of the ribonucleotide sugars in RNA G4s could be an important structural feature to be taken into account when designing selective RNA vs DNA G4-ligands [17] . The small molecule pyridostatin (PDS) (compound f in Fig. 1 ) was proved to be a generic dual bimolecular Tel DNA and TERRA G4
binder, contrary to its derivative carboxypyridostatin (cPDS) that exhibited high molecular selectivity for unimolecular RNA over DNA G4s [18] . Overall, based on such data, telomere TERRA RNA G4s could represent a potential target for anticancer agents directed against telomeres. Therefore, finding novel dual (as well as selective) G4 Tel DNA and TERRA binding ligands could represent an innovative strategy to enhance telomerase inhibition [19] .
Herein, to identify novel dual (or selective) Tel DNA and TERRA G4s binders we have employed a receptor-based virtual screening approach based on molecular docking and pharmacophore models targeting the bimolecular DNA G4 (Tel 2 ) of the 12-nt telomeric sequence 5'-TAGGGTTAGGGT-3'
(PDB code: 3CE5) [20] and its bimolecular RNA counterpart (TERRA 2 ) telomeric sequence 12-nt 5'-UAGGGUUAGGGU-3' (PDB code: 2KBP) [13] . The selected best candidates were submitted to biophysical evaluation. Among the 20 tested candidates, hit 7 ( Supplementary Fig. 4 ), having a 2- ,5] naphthyridin-12-yl)oxy scaffold, came out as the most interesting Tel 2 /TERRA 2 dual binder, not only from the theoretical approach but also from biophysical data which confirmed its "dual" activity since it showed good stabilization against both Tel 2 and TERRA 2 . In addition, hits 15 and 17 ( Supplementary Fig. 5 ) have been retrieved as interesting selective Tel 2 binders and further lead optimization studies could be undertaken in order to improve their affinity against Tel 2 or to achieve a certain activity over TERRA 2 . This work paves the way to understand at atomistic level the molecular features needed to obtain Tel/TERRA G4 binders through a Virtual Screening approach. The bimolecular human telomeric Tel 2 and TERRA 2 G4s, having PDB codes 3CE5 [20] and 2KBP [13] respectively, were selected to perform the structure-based virtual screening procedure since their sequence and topology were fully comparable. In particular, the PDB model 3CE5 represents the bimolecular X-ray structure (resolution of 2.5 Å) of the telomeric sequence 5'-TAGGGTTAGGGT-3', complexed with the known active ligand BRACO-19 in the presence of physiological concentrations of K + . The binding site of the ligand, BRACO-19, derived from the 3,6,9-trisubstituted acridine, is located at the interface of two G4 monomers both with parallel topology, included between a G-tetrad surface and a tetrad TATA. Indeed, the NMR PDB model 2KBP represents the ribonucleic sequence 5'-UAGGGUUAGGGU-3 ' in the presence of K + ion, equivalent to that of the 3CE5 model. In this study, both the X-Ray and NMR models were prepared and refined using the Protein Preparation Wizard implemented in Maestro ver. 9.7 [21] and, in addition, also the corresponding minimized structures were considered. With this aim, 5000
MATERIAL AND METHODS

Receptors preparation.
steps of the Polak Ribiere conjugate gradient algorithm [22] and the OPLS 2005 force field with the united atoms notation [23] as implemented in MacroModel version 10.3 [24] were used. A convergence criterion equal to 0.05 kJ·mol −1 ·Å was adopted and solvent effects were taken into account by means of the GB/SA implicit water solvation model [25] .
Actives and Decoys set preparation.
A test set of 9 known active G4 ligands a-i ( Fig. 1) characterized by different chemical scaffolds, were collected from literature data [26, 27] . They were selected based on their experimental affinity and activity toward bimolecular TERRA 2 and
Tel 2 G4s and their selectivity with respect to duplex DNA.
Please put Figure 1 here
The decoy set was taken from the Directory of Universal Decoys (DUD) [28] , which provided a library of 419 compounds, based on the structural similarity with respect to the active set. Both actives and decoys set were prepared considering the ionization state at physiological pH of 7.4 using the OPLS 2005 force field as implemented in the LigPrep platform ver. 2.9 of Maestro [29] . Supplementary Fig. 1 ). BRACO-19 was treated as flexible, while the receptor was kept rigid. The energy grid was built centering the docking box on guanine core and setting its outer box size to 45×45×45 Å. The scaling factor for the receptor Van der Waals radii was set to 1.0 and the number of generated poses was equal to 10. Following this protocol, docking simulations of the 9 actives and 419 decoys were carried out using the same redocking conditions for both Tel 2 and TERRA 2 G4s receptors.
Enrichment factor studies.
In order to take into account the effects of receptors flexibility, an ensemble of receptor conformations has been created (Supplementary Table 1 
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7 donor (HBD), hydrophobic (HY), negative ionizable (NI), positive ionizable (PI), aromatic ring (AR). Thus, the obtained pharmacophores were further modified increasing or decreasing the radius of tolerance of the previous features, inserting the excluded volumes in order to better describe the shape of the binding cavity and boost the complexity of the pharmacophore [33] . In particular, we manually modified the starting automatic pharmacophores on the basis of the information regarding DNA or RNA G4/ligand interactions reported in literature data and they are described in Results paragraph.
2.6 Structure-based pharmacophore validation. This procedure was performed using the same active/decoys set already used in the enrichment study. The hypotheses were evaluated on their EF and ROC curve. We used the Enrichment Factor (EF) as validation descriptor [34] [35] , that was calculated, for all the generated hypotheses, using the following eq. A.1:
where TP is the number of True Positive, n is the number of active and inactive compounds found from the pharmacophore hypothesis, A is the number of active compounds in the database and N is the database size (total of actives and inactives).
After evaluating the hypotheses based on the EF, the best ones were selected taking into account also the Receiver operating characteristic (ROC) curve and the percentage of the actives found for each hypothesis (Tables 2-3 
Database preparation and Virtual Screening (VS).
Each of the ten selected and validated pharmacophore models (Figs. 3-4) was used to perform VS separately using a multi-conformational database of natural compounds imported from the ZINC website. It included also the NPD 08 database developed by the University of Innsbruck, for a global number of ̴ 257000 natural compounds. A physically relevant ionization state (pH=7.4) was assigned to all compounds and the stereochemistry of chiral centres was determined. Afterwards, the so prepared database was subjected to an energy minimization step using the same protocol adopted for actives and decoys set
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8 [13] . Hence, two databases were created: one including the merged hits identified for each pharmacophore model of Tel 2 , the second formed by the merged hits found for TERRA 2 RNA G4.
The resulting two databases for TERRA 2 and Tel 2 were de-duplicated and further reduced in size by applying the popular empirical Lipinski's rule of five. Molecules that successfully passed this filter were further submitted to docking studies.
Similarity clusterization.
To reduce the number of compounds to be tested on Tel 2 , we clustered the obtained hits on the basis of their volume overlap, using the average Linkage method.
Finally, for each cluster we selected the compound with the best Glide Score (GScore).
Selection for biological testing. After the careful visual inspection analysis of the best docking
poses and the evaluation of their commercial availability, the best 20 final hits were purchased and submitted to biological tests.
Oligonucleotides used in the biophysical analysis. All desalted oligonucleotides were
purchased from Sigma-Aldrich, Milan, Italy (Table 1) .
Please put Table 1 Compounds were added at 2x G4 final concentration (8-16 μM). CD spectra were recorded after 24
h from 20°C to 95°C, with temperature increase of 5°C. T m values were calculated according to the van't Hoff equation, applied for a two state transition from a folded to unfolded state, assuming that the heat capacity of the folded and unfolded states are equal [36] . We decided to select all the generated five pharmacophore hypothesis, that are represented in Table 2 and discussed in the Discussion section.
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Please put Figure 3 here
Please put Table 2 here 3.2 Generation of TERRA 2 Structure-based pharmacophore models. As concerns the bimolecular telomeric RNA G4 (TERRA 2 ), eight pharmacophore hypotheses were generated; their feature details are reported in Table 3 and more thoroughly discussed in Discussion section. Also in the TERRA 2 , the bottom position was the preferred binding site, probably because at the top position residues RU1 and RU13 interact with each other, thus limiting the exposure of the planar G-tetrad formed by RG3:RG9:RG15:RG21 residues. Consequently, more favourable interactions between the planar moieties of the ligands are established with RG5, RG11 and RG23 residues.
Specifically, the T-Hypo1 was generated from the docking complex of the Naphtalene diimide with a dimethylamino-propyl side chain (compound a in Fig. 1 ) whose positively charged side chains
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engage electrostatic interactions with the phosphodiesterasic portion of TERRA 2 . Similar binding modes were observed in the docking complexes of the Naphtalene diimide having the propylaminopyrrolidin side chains (compound b in Fig. 1 ) and the Naphtalene diimide with the bisdimethylamino-propyl-hydroxypropyl side chains (compound c in Fig. 3 We decided to select only five pharmacophore hypotheses (Fig. 4) . In particular, T-Hypo1, THypo2, T-Hypo3 and T-Hypo4 were selected due to the good EF values, while T-Hypo6 was chosen taking into account its ROC curve ( Supplementary Fig. 3B ) and the high percentage of active compounds found.
Please put Figure 4 here
Please put Table 3 here 3.3 Database screening. From the above validation methods, it turned out that five pharmacophore hypotheses for Tel 2 and five for TERRA 2 had a good ability to distinguish the active from decoy sets and to retrieve the greatest number of active compounds. These best pharmacophores were used
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12 separately to screen a database of around ~260000 compounds. The ranked molecules identified for each Tel 2 pharmacophore model were merged, thus obtaining 18725 hits for the deoxyribonucleic G4 and the same procedure was performed for hits resulting from virtual screening of TERRA 2 , collecting 16578 molecules. Then, Lipinski's rule of five was used to eliminate the non-drug like compounds from the hit molecules thus obtaining 12212 and 12387 molecules respectively for Tel 2 and TERRA 2 that were further subjected to ensemble docking simulations on their theoretical target. Table 2 .
3.5 Circular dichroism screening. The available hits were screened for their ability to stabilize the bimolecular G4 targets by melting circular dichroism spectroscopy (CD). This technique allowed us to discriminate quadruplex topologies and to calculate melting temperatures (T m ) both in the absence and presence of the compounds.
Hits 1-7 and 8-20, selected by the computational screening as putative binders of TERRA 2 and Tel 2 , respectively, were initially tested against their computationally defined targets (Tables 4-5 ). Hit 7 was the only candidate able to stabilize TERRA 2 , with a ΔT m of 6.8 °C (Table 4) , while hits 15 and 17 were the best stabilizers of Tel 2 .
Please put Table 4 here
The three best active hits did not modify the dimeric propeller-like parallel G4 conformation of TERRA 2 [13] [14] , the CD spectrum of which was characterized by a negative peak at 240 nm and a
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positive peak at 265 nm also in the presence of the compounds (Figs. 5 A-B and supplementary Fig.   7 ). In contrast, they modified the mixed-type conformation of Tel 2 . In particular, the CD spectrum of the oligonucleotide itself showed a negative peak at 240 nm, a positive peak at 265 nm and a shoulder at 295 nm (Fig. 5 C) , as the result of two interconverting conformations [37] [38] . In the presence of the compounds the equilibrium was shifted towards the parallel-like topology, resulting in the decrease of the shoulder at 295 nm and increase of the dichroic signal at 265 nm, especially for hits 15 and 17 (Figs. 5 D-F) .
Please put Figure 5 here
Because TERRA 2 was much more stable that Tel 2 at 100 mM (T m 71.0°C and 52.6, respectively) ( on TERRA 2 at 2 mM K + , conditions at which destabilization rather than stabilization of the G4 structure was obtained. This last data may be an indication that TERRA 2 G4 folding in such low K + concentration is so poor that stabilization is detected only by compounds able to induce the G4 conformation. These data indicate that a meaningful direct comparison of the binding efficiency towards oligonucleotides with different T m is hardly achievable by CD.
Please put Table 5 here 3.6 Mass Spectrometry (MS) Competition Assay. To detect which of the two G4 oligonucleotides (TERRA 2 or Tel 2 ) was preferentially bound by the selected hits, an electrospray mass spectrometry method was set up. The gentle ionization conditions of electrospray allow to transfer intact biomolecules and non-covalent complexes in the gas phase to obtain a snap-shot of the species present in solution and their relative concentration [39] [40] . By the relative intensity of the bound/unbound species, it is possible to gather information on the relative binding affinities and the specificity toward the different investigated oligonucleotides [41] [42] . In our experimental procedure, TERRA 2 and Tel 2 were separately folded and mixed just before the addition of the tested
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compounds to minimize formation of hybrid DNA/RNA G4s. Surprisingly, the formation of the hybrid species was not observed, even after extended incubation times (i.e. up to 16 h) ( Supplementary Fig. 8 ). Both TERRA 2 and Tel 2 were detected mostly as dimers, as evinced by the coordination of two K + ions, which is consistent with the formation of dimeric G4s with three guanine quartets. The monomeric peak was almost absent in TERRA 2 solution, while was detectable, even though at low level, in the Tel 2 sample, confirming the lower stability of the Tel 2 G4. Double-stranded DNA (dsDNA) was also used alongside the G4 folded oligonucleotide to test the hits' selectivity towards G4s. DsDNA did not modify G4 formation (Supplementary Fig. 9 ).
Each compound was competed for the binding to TERRA 2 /Tel 2 , TERRA 2 /dsDNA, Tel 2 /dsDNA (Table 6 ) ( Fig. 6 and supplementary Figs. 10-12 ). The relative binding affinities (BA) calculated by the intensity of the peaks are reported in Table 6 . Interestingly, no adducts to monomeric RNA or DNA were obtained ( Fig. 6 and supplementary Figs. 10-12).
Hit 7 showed a much higher affinity for TERRA 2 compared to Tel 2 and dsDNA ( Supplementary Fig. 11) ; hit 17 showed similar BA towards TERRA 2 and Tel 2 and low binding affinity towards dsDNA (Supplementary Fig. 12 ). The affinity towards dsDNA was similarly low for all compounds (Table 6) .
Please put Table 6 Hypo2 and the T-Hypo4, respectively for Tel 2 and TERRA 2 , were equally able to discover the hit 7
( Fig. 7 A-B) . The two pharmacophore models consist in the same type of features (2 HBD, 1 AR) with very similar interatomic distances (Fig. 7 C-D) , thus justifying the dual activity of 7. Only the greater distance between the two HBD groups is mainly due to the flexibility of the side chain. The positive ionisable feature (PI) does not seem to be discriminant between the two targets.
Please put Figure 7 here
Hit 15 was found only by the D-Hypo1 consisting of one AR, one HBD and one HBA (Supplementary Fig. 13 A-B) . Also in this case the selectivity of this compound towards Tel 2 can be explained by looking at the interatomic distance of the pharmacophore features that are much less spaced compared to those of T-Hypo4 and D-Hypo2 (Fig. 7 A-B) and the presence of one HBA.
Hit 17 was retrieved only by D-Hypo3 (whose superimposition is shown in supplementary Fig. 14   A- Please put Table 7 here
As previously stated, all the three hits 7, 15 and 17 favourably interact in the same binding site for both Tel 2 and TERRA 2 located close to the guanine residues G5:G11:G17:G23 which, for Table 7) .
The only exception is 17, which does not form any stacking interaction against Tel 2 , but is able to establish the highest number of good contacts with respect to its binding mode against TERRA 2 . In particular, residues RU12 and RU24 in TERRA 2 G4 assume a conformation that does not allow the good accommodation of the ligand aromatic planar portion on the tetrad, since the lack of the A C C E P T E D M A N U S C R I P T
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16 methyl group in the uracil and the resulting reduced steric hindrance of the hydrogen atom make these residues more flexible ( Fig. 8 A-F) .
Please put Figure 8 here
DISCUSSION
As widely reported in literature, telomerase activity requires an unfolded single-stranded substrate.
Hence, G4 formation directly inhibits telomerase elongation in vitro [43] and therefore ligands that selectively bind to and stabilize G4 structures may interfere with telomere conformation and telomere elongation. Since telomerase levels are high in the majority of malignant cells and largely absent in normal cells, these G4 ligands have been proposed as selective anti-cancer agents.
Given the few number of available telomeric G4 RNA selective binders to date [26] , our Virtual
Screening approach can be considered the first step towards the discovery of novel promising ligands able to stabilize TERRA 2 structures. In particular, our protocol allowed us to identify hit 7, characterized by a naphthyridin scaffold with a ((dimethylamino)propyl)acetamide side chain, as a dual Tel 2 /TERRA 2 binder: hit 7 matches Tel 2 and TERRA 2 pharmacophore features that display very similar interatomic distances and angles, and it exerts good theoretical affinity for both structures, as gathered from docking calculations. In vitro, hit 7 displays thermal stabilization effects on both target nucleic acids even though with a visible preferential stabilization on TERRA 2 as gathered by both CD ad MS competition analysis. On the contrary, Hits 15 and 17, having respectively a furo-chromen and benzofuran scaffolds, show preferential tendency to stabilize Tel 2 G4 rather than its RNA counterpart. Such a finding probably relates to a reduced π-π interactions network of both hits due to lower accessibility of the G-tetrad surface linked to the steric hindrance of the terminal uracils RU12 and RU24. Moreover, a poor geometric overlapping between the pharmacophore features of TERRA 2 with both hits 15 and 17 was observed, thus rationalizing their preferential recognition of Tel 2 . Compound 17 behaviour confirmed also our previous findings on the potential of the furo-chromen scaffold [44] . Optimization on this scaffold is already in progress.
CONCLUSIONS
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